Amylin Pharmaceuticals, Inc. Financial Analysis Report

Amylin Pharmaceuticals, Inc.
Financial Analysis Report

Prepared by: Danielle Davis and Liz Van Hemel
Presented to: Dr. Mohammed Ahmed
December 15, 2009

Amylin Pharmaceuticals, Inc. Financial Analysis Report

1

Table of Contents
EXECUTIVE SUMMARY

5

INTRODUCTION

6

Company Background
Mission
Goals and Objectives
Revenues
Assets
Growth Rate
Market Position
Company Strategies/Products
Management and Corporate Culture
Strategic Partnerships
MARKET OUTLOOK
General Overview
Historical Performance
Future Outlook
INDUSTRY OUTLOOK
Nature of the Industry
Industry Composition
Industry Growth
Opportunities and Threats
Future Outlook
FINANCIAL STATEMENT ANALYSIS
Income Statement
Common Size Income Statement
Balance Sheet
Common Size Balance Sheet
Statement of Cash Flows
Cash Flow Analysis
Financial Ratio Analysis

6
7
7
8
11
14
15
16
18
19
20
20
21
23
23
23
26
26
27
29
31
31
32
34
35
37
40
43

Amylin Pharmaceuticals, Inc. Financial Analysis Report
STRENGTHS AND WEAKNESSES ANALYSIS
Financial Ratios Industry Comparison
Strengths
Weaknesses
Reasons for Level of Performance
FINANCIAL FORECASTING

2
54
54
57
57
61
62

Growth Rate Data
Pro Forma Income Statement
Pro Forma Balance Sheet

62
68
70

CAPITAL STRUCTURE ANALYSIS

72

VALUATION ANALYSIS

77

Book Value
Market Value
Common Stock Valuation
Liquidation Value

77
77
77
78

BANKRUPTCY ANALYSIS

79

VALUE-BASED FINANCIAL ANALYSIS

81

RECOMMENDATIONS

82

REFERENCES

84

APPENDIX

88

Amylin Pharmaceuticals, Inc. Financial Analysis Report

3

List of Tables
Table 1:

Product Sales (2006-2008)

8

Table 2:

Revenues from Collaborative Agreements (2006-2008)

9

Table 3:

Total Revenues (2004-2008)

10

Table 4:

First Six Months Total Revenue Comparison (2008 & 2009)

10

Table 5:

Amylin & Top Competitors Total Revenue Comparison (2006-2008)

11